Menu
Not yet recruiting NCT06803186

High Power Laser on Suboccipital Myoelectrical Activities and Quality of Life in Patients With Cervicogenic Headache

No phase Interventional Cervicogenic Headache

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: High-power laser therapy, Placebo (PL) high power laser, Conventional physical therapy program.
Who it may be relevant to
Registry conditions: Cervicogenic Headache. Basic parameters: 30 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of High Power Laser Therapy on Myoelectrical Activities of Suboccipital Muscles and Quality of Life in Patients With Cervicogenic Headache

Overview

The study will be conducted: To investigate the effect of high-power laser on myoelectrical activities of suboccipital muscles in patients with cervicogenic headache. * To investigate the effect of high-power laser on pain in patients with cervicogenic headache. * To investigate the effect of high-power laser on quality of life in patients with cervicogenic headache.

Detailed description

Cervicogenic headache is a classification of headache in which pain is referred from the cervical spine. This category of headache is typically chronic, presented as unilateral cephalgia, spreading over the occipital, temporal, and frontal regions and is believed to be caused by musculoskeletal dysfunction of the neck.

In high-power laser therapy (HPLT) there is an increase in mitochondrial oxidative reaction and adenosine phosphate (photobiology effect). The pain-releasing effect of HPLT is provided by reducing the transmission of painful stimuli and increased morphine mimetic factors. It has rapidly induced photochemical and photothermal effects, increasing blood flow, cell metabolism, and vascular permeability.

In a recent study on exercise for cervicogenic headache, Subjects reported significant decreases in the frequency, intensity, and duration of their headaches.

To our knowledge there is no study was found to investigate the effect of high-power laser therapy (HPLT) on myoelectrical activities of suboccipital muscles, pain and functional activities in patients with cervicogenic headache.

So, this study aimed to determine the effect of high power laser therapy (HPLT) on myoelectrical activities of suboccipital muscles , pain and quality of life in patients with cervicogenic headache.

Interventions

  • Device High-power laser therapy
    High power laser therapy (HPLT) with a neodymium-yttrium aluminum garnet laser with a pulsating waveform produced by a ( Hilterapia device , ASA, Arcugnano, Vicenza, Italy). It will be set at the following parameters: Nd:YAG laser with pulsed emission (1064 nm), very high peak powers with average power 6 W, high levels of fluency (760 mJ/cm energy density), short pulse duration (250 μs), low frequency (10-40 Hz), and 5-cm probe diameter for 15 minutes. The scanning will be performed longitudina
  • Device Placebo (PL) high power laser
    laser probe scanning will be applied to the same areas as that applied in the HPLT procedure. PL will be applied while the lights of the device will be on, with no current flowing through the device. Placebo therapy will be applied at the same frequency as HPLT (Three sessions a week for six weeks for a total of 18 sessions; one session will be lasted 15 minutes).
  • Other Conventional physical therapy program
    A specific program of 45-min exercise of three sessions a week for six weeks for a total of 18 sessions. Corrective exercises will be performed initially by stretching exercises for(suboccipital, upper trapezeius, scalene, levator scapulae, sternocleidomastoid, pectoralis major/minor muscles) will be given four repetitions with 30 second hold. each with 3 seconds rest between each stretch Then, strengthening exercises will be performed initially in an isometric manner for weak muscles (deep cerv

Primary outcome measures

  • Myoelectrical activity of suboccipital muscle [Time frame: 6 weeks]
  • Neck Disability Index (NDI) [Time frame: 6 weeks]
  • Quality of life (QoL) assessment [Time frame: 6 weeks]
Secondary outcome measures (2)
  • Pain intensity [Time frame: 6 weeks]
  • Headache impact test-6 (The HIT-6) [Time frame: 6 weeks]

Eligibility criteria

Inclusion criteria

  • Patients suffering from cervicogenic headache based on international headache society "IHS" criteria for cervicogenic headache.
  • Unilateral cervical radiculopathy (Upper cervical C1 -C4).
  • Age ranged from 30 to 50 years.
  • Neck pain referring unilaterally to suboccipital region.
  • The pain and restriction in C1-C2 rotation by Cervical Flexion-Rotation Test (FRT )
  • Intensifying headache by manual pressure to upper cervical muscles and joints.
  • Experiencing headache at least once per week for the last 6 months.
  • Patients will be referred by neurological consultants.
  • Body mass index (18.5 - 29. 9 Kg/m2).
  • Moderate (45-74) to severe (75-100) neck pain on the visual analogue scale.

Exclusion criteria

  • Cervical myelopathy, cervical instability, cervical fracture cervical surgery with evidence of pyramidal, posterior column disorders.
  • History of any neurologic disease ( stroke, MS , cerebellar disorders , vestibular dysfunction and neuropathy )Pregnant or breastfeeding women
  • Other types of headaches (migraine - cluster headaches- tension headache)
  • Patients of systemic diseases such as rheumatoid arthritis
  • contraindication to high-power Laser such as:
  • Wounds or skin changes in the neck or shoulder region (such as psoriasis, scars, or burns).
  • Photosensitivity diagnosis.
  • Tumors of some type have been diagnosed in the last 5 years.
  • Presence of solar urticaria or adverse reactions to sunlight.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Ahmed Karem Youssef Tawfik — Cairo

Identifiers

NCT: NCT06803186 · P.T.REC/012/005470

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗